Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia.
about
Understanding phenotypic variation in rodent models with germline Apc mutationsAnimal models of colorectal cancerThe role of testosterone in colorectal carcinoma: pathomechanisms and open questionsCharacterisation of a C1qtnf5 Ser163Arg knock-in mouse model of late-onset retinal macular degenerationThe expanding role of mouse genetics for understanding human biology and diseaseFive quantitative trait loci control radiation-induced adenoma multiplicity in Mom1R Apc Min/+ miceGenetic basis of variation in adenoma multiplicity in ApcMin/+ Mom1S mice.Modifier genes and the plasticity of genetic networks in mice.Sex disparity in colonic adenomagenesis involves promotion by male hormones, not protection by female hormonesIdentification of Mom12 and Mom13, two novel modifier loci of Apc (Min) -mediated intestinal tumorigenesisLoss of miR-10a activates lpo and collaborates with activated Wnt signaling in inducing intestinal neoplasia in female miceMouse models for genetic dissection of polygenic gastrointestinal diseases.The modifier of Min 2 (Mom2) locus: embryonic lethality of a mutation in the Atp5a1 gene suggests a novel mechanism of polyp suppression.Identification of Mom7, a novel modifier of Apc(Min/+) on mouse chromosome 18.Genetic analysis of intestinal polyp development in Collaborative Cross mice carrying the Apc (Min/+) mutation.The art and design of genetic screens: mouse.Identification of five novel modifier loci of Apc(Min) harbored in the BXH14 recombinant inbred strain.Genetic variables that influence phenotype.More than two decades of Apc modeling in rodentsCables1 is a tumor suppressor gene that regulates intestinal tumor progression in Apc(Min) mice.Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and diseaseMyeloid translocation genes differentially regulate colorectal cancer programs.The importance of a large sample cohort for studies on modifier genes influencing disease severity in FAP patients.APC and its modifiers in colon cancer.Animal models of human genetic diseases: do they need to be faithful to be useful?Colorectal cancer mouse models: integrating inflammation and the stroma.What are the best routes to effectively model human colorectal cancer?Giving APCmin tumours a SPARC.The Ron receptor tyrosine kinase is not required for adenoma formation in Apc(Min/+) miceLigand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms.Genetic dissection of the Mom5 modifier locus and evaluation of Mom5 candidate genes.Phospholipase A2 group IIA expression correlates with prolonged survival in gastric cancer
P2860
Q26824920-E60BEEB3-1AD5-4381-9F9F-F32B6C70A081Q27009170-CC2BA769-DF40-480F-BA9C-DADF910C598DQ28077795-C5563F9C-54E7-457C-903F-6397D5AF2AFBQ28478012-4BD7C50F-8216-4CE2-88D4-AD45EA051696Q33388684-2D4DE550-B095-42E5-9DB8-559B18327DE1Q33405757-91FA2EA5-B195-43BF-BCFD-444C5741F0E9Q33863400-4185D260-1DC8-48B3-9C2A-AFF38F110476Q34236664-278CA129-91AE-4C73-B622-8B591A79CBFEQ34581183-F89BAA63-7A7E-4121-8A87-0D1A14622757Q35002366-F5E269BF-781B-4B70-8468-BC92FE73F299Q35034369-CB3D1C9F-9DC1-4D4C-B6E6-AFDC5020E505Q35067030-5C9CFC97-DB50-46E7-8E5C-83384F4269F5Q35757899-53E5736B-C800-4EFE-B74E-3E8274C2C2CEQ35846272-5ACCE801-1F7C-4339-B189-1B178BC1C7BBQ35929052-4A2865F3-F888-4266-BBCE-DABC906E5D08Q36160830-058CC05F-7D66-4418-B1EF-AC4DB443A5AAQ36402010-F414C7C9-6072-468F-A8B5-2CA27B4FCD1CQ36425326-3E2D307B-11CE-4A15-BEE8-04C769D2B9F9Q36847248-CEC383F7-A9B9-46BC-B34E-BE017274A46CQ37092692-0B80501F-35C7-4240-BD8B-58A8104B02AFQ37212217-927C78D2-2A50-4F67-B045-80EAB4915E83Q37478599-3B23C80F-6F29-4E31-963D-8CC8B5F06F07Q37533240-E2DCF140-7339-411D-A0AB-D647DCCB247CQ37635945-D2D09124-BD0E-49FA-8CB1-5461636F1691Q37872654-24E33457-4E23-4FFF-8CA4-1549629C921BQ37970398-3B299FF4-6EDF-4D9F-B07D-601FBC9F99A2Q38087005-D4927842-89EB-4354-A6DA-ABE22D41EFD0Q41110409-28F7AAD8-B18F-4908-9EFD-B8EFEE006269Q42738854-AACEC206-ED5A-4474-B463-E7BCE2F583EBQ46983610-604EE596-99ED-4BD5-B495-5EE90C6E7A5AQ53506336-B34D8188-0242-410F-827A-FBBAC1440D60Q57280364-6B47FB6D-3BD6-4D8A-80A0-182F7CBE9ED7
P2860
Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Identification of the modifier ...... -induced intestinal neoplasia.
@ast
Identification of the modifier ...... -induced intestinal neoplasia.
@en
type
label
Identification of the modifier ...... -induced intestinal neoplasia.
@ast
Identification of the modifier ...... -induced intestinal neoplasia.
@en
prefLabel
Identification of the modifier ...... -induced intestinal neoplasia.
@ast
Identification of the modifier ...... -induced intestinal neoplasia.
@en
P2093
P2860
P356
P1433
P1476
Identification of the modifier ...... c-induced intestinal neoplasia
@en
P2093
Karen A Silverman
Linda D Siracusa
Revati Koratkar
P2860
P356
10.1101/GR.206002
P577
2002-01-01T00:00:00Z